Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (28 ops.)
Latest filing published 03 Apr 2026 for RESMED INC, €194k. Read the official filing
Filing timeline
BuySaleBrett Sandercock
Insider track record
Disclosed buys
0
Disclosed sells
28
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Brett Sandercock: trading record in brief
This profile gathers the share dealings of Brett Sandercock in ResMed Inc, where the filings describe the role as finance chief. The record holds 53 filings, for trades running from 10 May 2021 to 1 April 2026.
Every open-market trade on record is a sale: 28 sales worth €13.8M. Besides market trades, the filings include 8 share grants and 17 option exercises. In 2026 alone, the filings show no purchases and 4 sales.
The latest filing, published on 3 April 2026, reports an open-market sale of €194k in ResMed Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Brett Sandercock
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations53 total
1,000 shares@ US$224.310.7% of flowResMed Common StockSEC:0000943819-26-000020:0
1,000 shares@ US$254.301.0% of flowResMed Common StockSEC:0000943819-26-000013:0
1,000 shares@ US$257.031.0% of flowResMed Common StockSEC:0000943819-26-000008:0
1,000 shares@ US$241.751.0% of flowResMed Common StockSEC:0000943819-26-000002:0
1,000 shares@ US$244.161.0% of flowResMed Common StockSEC:0000943819-25-000184:0
2,710 shares0ResMed Common StockSEC:0000943819-25-000171:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000092:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000084:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000052:0
5,462 shares0ResMed Common StockSEC:0000943819-25-000040:0
2,000 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000032:0
1,966 shares@ US$101.640.9% of flowResMed Common StockSEC:0000943819-25-000025:0
1,000 shares@ US$243.781.1% of flowResMed Common StockSEC:0000943819-25-000011:0
3,644 shares@ US$244.593.6% of flowResMed Common StockSEC:0001127602-25-015607:0
1,000 shares@ US$215.580.7% of flowResMed Common StockSEC:0001127602-25-011925:0
1,000 shares@ US$230.360.8% of flowResMed Common StockSEC:0001127602-25-009188:0
1,000 shares@ US$238.980.9% of flowResMed Common StockSEC:0001127602-25-004042:0
1,000 shares@ US$234.040.9% of flowResMed Common StockSEC:0001127602-25-001067:0
1,000 shares@ US$244.230.9% of flowResMed Common StockSEC:0001127602-24-029095:0
1,000 shares@ US$249.000.9% of flowResMed Common StockSEC:0001127602-24-027030:0
1,000 shares@ US$233.470.8% of flowResMed Common StockSEC:0001127602-24-025369:0
1,000 shares@ US$246.420.8% of flowResMed Common StockSEC:0001127602-24-023758:0
7,915 shares0ResMed Common StockSEC:0001127602-24-022304:0
1,000 shares@ US$212.160.7% of flowResMed Common StockSEC:0001127602-24-021984:0
1,000 shares@ US$194.350.7% of flowResMed Common StockSEC:0001127602-24-020248:0
25 of 53 declarations
